Prediabetes and diabetes accelerate cognitive decline and predict microvascular lesions: A population‐based cohort study
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Introduction: The impact of prediabetes and diabetes on cognitive decline and the potential underlying mechanisms remain unclear. We investigated whether prediabetes and diabetes accelerate cognitive decline and brain aging, and the initial pathological changes linked to microvascular processes. Methods: Nine‐year longitudinal data from the Swedish National Study on Aging and Care‐Kungsholmen (n = 2746, age ≥60 years) and the magnetic resonance imaging subsample (n = 455) were used. Cognitive function was assessed with Mini‐Mental State Examination. Brain magnetic resonance imaging markers included total brain tissue, white matter, gray matter, white matter hyperintensities, and hippocampal volumes. Results: Compared with diabetes‐free status, prediabetes and diabetes were independently associated with accelerated cognitive decline. Prediabetes was cross‐sectionally associated with smaller total brain tissue volume (P < .01), particularly smaller white matter volume. Diabetes was associated with larger white matter hyperintensities volume. Longitudinally, diabetes was associated with faster white matter hyperintensities accumulation. No associations between prediabetes or diabetes and hippocampal volume were found. Discussion: Diabetes and prediabetes accelerate cognitive decline and might predict microvascular lesions among dementia‐free older adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00569-x · Cited by 8,610
Ashburner, J., & Friston, K. J. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.02.018 · Cited by 7,507
Wardlaw, J. M., Smith, E. E., Biessels, G. J., Cordonnier, C., Fazekas, F., Frayne, R., Lindley, R. I., O'Brien, J. T., Barkhof, F., Benavente, O. R., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70124-8 · Cited by 5,544 · cited 2×
“WMH are part of SVD and reflect microvascular lesions in the cerebral white matter, likely due to demyelination and axonal loss [13].”
BackgroundHypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806 · cited 1×
“However, the patterns of cognitive decline in the MRI subsample mirrored those observed in the SNAC-K cohort, and it is known that brain changes occur years before clinically evident cognitive decline [43].”
ResultStandards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969 · cited 1×
“Hyperglycemia can induce neuroinflammation and oxidative stress, causing loss of pericytes, which are vascular cells that together with endothelial cells, glial cells, and neurons form the neurovascular unit, directly involved in maintaining the integrity of the blood-brain barrier and brain homeostasis [41].”
BackgroundRevising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869 · cited 1×
“Cerebral small vessel disease (SVD)—including white matter hyperintensities (WMH) and brain atrophy—are major contributors to vascular dementia [13], whereas atrophy of the medial temporal lobe (containing the hippocampus) is a marker of neurodegeneration in Alzheimer’s disease (AD) [14].”
BackgroundThe changing face of diabetes complications
Gregg, E. W., Sattar, N., & Ali, M. K. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30010-9 · Cited by 612 · cited 1×
“All ri type 2 diabetes (hereafter, diabetes), which account for about 90% of all diabetic cases, can damage small and large blood vessels, resulting in disabling complications such as retinopathy, nephropathy, neuropathy, cardiovascular diseases, and cerebrovascular diseases [1,2].”
BackgroundJack, C. R., Twomey, C. K., Zinsmeister, A. R., Sharbrough, F. W., Petersen, R. C., & Cascino, G. D. (1989) · Radiology · doi:10.1148/radiology.172.2.2748838 · Cited by 592 · cited 1×
“All MRI measurements were adjusted by total intracranial volume and age [34], and the adjusted volumeswere used in data analyses.”
MethodBiessels, G. J., Strachan, M. W. J., Visseren, F. L. J., Kappelle, L. J., & Whitmer, R. A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70088-3 · Cited by 551 · cited 2×
“Findings from many population-based studies consistently show an increased risk of dementia in people with diabetes or prediabetes [4,5].”
BackgroundDiabetes, impaired fasting glucose, and development of cognitive impairment in older women
Yaffe, K., Blackwell, T., Kanaya, A. M., Davidowitz, N., Barrett-Connor, E., & Krueger, K. (2004) · Neurology · doi:10.1212/01.wnl.0000134666.64593.ba · Cited by 520 · cited 1×
“Increased HbA1c levels have been associated with faster decline in memory and reasoning in middle-aged individuals with diabetes [12], but other cohort studies did not find such associations [35,36].”
BackgroundLagergren, M., Fratiglioni, L., Hallberg, I. R., Berglund, J., Elmståhl, S., Hagberg, B., Holst, G., Rennemark, M., Sjolund, B.-M., Thorslund, M., et al. (2004) · Aging Clinical and Experimental Research · doi:10.1007/bf03324546 · Cited by 500
Self-citationYaffe, K. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.6176 · Cited by 441 · cited 2×
“Increased HbA1c levels have been associated with faster decline in memory and reasoning in middle-aged individuals with diabetes [12], but other cohort studies did not find such associations [35,36].”
BackgroundResultCalderón-Larrañaga, A., Vetrano, D. L., Onder, G., Gimeno-Feliu, L. A., Coscollar-Santaliestra, C., Carfí, A., Pisciotta, M. S., Angleman, S., Melis, R. J. F., Santoni, G., et al. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw233 · Cited by 425 · cited 1×
“International Classification of Disease, tenth revision (International Classification of Disease 10; described in Appendix A), were used to identify the chronic medical conditions, such as heart diseases (atrial fibrillation, bradycardias and conduction diseases, ischemic heart disease, cardiac valve diseases, and hea…”
MethodSelf-citationDavatzikos, C., Xu, F., An, Y., Fan, Y., & Resnick, S. M. (2009) · Brain · doi:10.1093/brain/awp091 · Cited by 315 · cited 1×
“Indeed, the simple brain measure of HV may not be as specific and sensitive for AD as other more complex brain MRI measures based on high-dimensional pattern classification methods, such as the Spatial Pattern of Abnormality for Recognition of Early AD index, which may provide a better representation of the underlying…”
BackgroundType 2 diabetes mellitus and biomarkers of neurodegeneration
Moran, C., Beare, R., Phan, T. G., Bruce, D. G., Callisaya, M. L., Srikanth, V., Moran, C., Beare, R., Phan, T. G., Bruce, D. G., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001982 · Cited by 298 · cited 3×
“Some studies observed greater WMHV in diabetes [17,20], whereas others did not [16,19].”
BackgroundResultBrain Changes Underlying Cognitive Dysfunction in Diabetes: What Can We Learn From MRI?
Biessels, G. J., & Reijmer, Y. D. (2014) · Diabetes · doi:10.2337/db14-0348 · Cited by 295
A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus
on behalf of the Utrecht Diabetic Encephalopathy Study Group, van den Berg, E., Reijmer, Y. D., de Bresser, J., Kessels, R. P. C., Kappelle, L. J., & Biessels, G. J. (2010) · Diabetologia · doi:10.1007/s00125-009-1571-9 · Cited by 254
Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology
Abner, E. L., Nelson, P. T., Kryscio, R. J., Schmitt, F. A., Fardo, D. W., Woltjer, R. L., Cairns, N. J., Yu, L., Dodge, H. H., Xiong, C., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.12.006 · Cited by 233 · cited 1×
“Together, these data point toward the existence of a vasculopathic process, especially in the microvasculature, underlying the onset and progression of prediabetes- and diabetes-related cognitive decline rather than an AD neurodegenerative process [15,38].”
BackgroundThe Effect of Borderline Diabetes on the Risk of Dementia and Alzheimer’s Disease
Xu, W., Qiu, C., Winblad, B., & Fratiglioni, L. (2007) · Diabetes · doi:10.2337/db06-0879 · Cited by 218
Self-citationAssociation of type 2 diabetes with brain atrophy and cognitive impairment
Roberts, R. O., Knopman, D. S., Przybelski, S. A., Mielke, M. M., Kantarci, K., Preboske, G. M., Senjem, M. L., Pankratz, V. S., Geda, Y. E., Boeve, B. F., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000269 · Cited by 211
Tuligenga, R. H., Dugravot, A., Tabák, A. G., Elbaz, A., Brunner, E. J., Kivimäki, M., & Singh-Manoux, A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70192-x · Cited by 211 · cited 1×
“However, the few previous longitudinal studies examining the role of glycemic control in diabetes-related cognitive decline have yielded mixed results [11,35,36].”
ResultProgression of Cerebral Atrophy and White Matter Hyperintensities in Patients With Type 2 Diabetes
de Bresser, J., Tiehuis, A. M., van den Berg, E., Reijmer, Y. D., Jongen, C., Kappelle, L. J., Mali, W. P., Viergever, M. A., Biessels, G. J., & on behalf of the Utrecht Diabetic Encephalopathy Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1923 · Cited by 181
Effects of Type 2 Diabetes on 12-Year Cognitive Change
Spauwen, P. J. J., Köhler, S., Verhey, F. R. J., Stehouwer, C. D. A., & van Boxtel, M. P. J. (2013) · Diabetes Care · doi:10.2337/dc12-0746 · Cited by 153 · cited 1×
“Before dementia, diabetes has been related to deficits in different cognitive domains [4] and to accelerate cognitive decline, especially in psychomotor speed and executive function [6,7].”
BackgroundInfluence of Type 2 Diabetes on Brain Volumes and Changes in Brain Volumes
Espeland, M. A., Bryan, R. N., Goveas, J. S., Robinson, J. G., Siddiqui, M., Liu, S., Hogan, P. E., Casanova, R., Coker, L. H., Yaffe, K. S., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0555 · Cited by 153
Glucose indices are associated with cognitive and structural brain measures in young adults
Weinstein, G., Maillard, P., Himali, J. J., Beiser, A. S., Au, R., Wolf, P. A., Seshadri, S., & DeCarli, C. (2015) · Neurology · doi:10.1212/wnl.0000000000001655 · Cited by 149 · cited 4×
“Some studies observed greater WMHV in diabetes [17,20], whereas others did not [16,19].”
BackgroundResultInfluentialBamberg, F., Hetterich, H., Rospleszcz, S., Lorbeer, R., Auweter, S. D., Schlett, C. L., Schafnitzel, A., Bayerl, C., Schindler, A., Saam, T., et al. (2017) · Diabetes · doi:10.2337/db16-0630 · Cited by 138
Schneider, A. L. C., Selvin, E., Sharrett, A. R., Griswold, M. E., Coresh, J., Jack, C. R., Knopman, D. S., Mosley, T. H., & Gottesman, R. F. (2017) · Diabetes Care · doi:10.2337/dc17-1185 · Cited by 130
Salameh, T. S., Shah, G. N., Price, T. O., Hayden, M. R., & Banks, W. A. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.237057 · Cited by 104 · cited 2×
“In turn, dysfunction of blood-brain barrier permeability may lead to changes in the brain microvasculature and, over time, to white matter abnormalities [40,42].”
BackgroundKöhncke, Y., Laukka, E. J., Brehmer, Y., Kalpouzos, G., Li, T., Fratiglioni, L., Bäckman, L., & Lövdén, M. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.013 · Cited by 92
Self-citationGlycated haemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) study
Christman, A. L., Matsushita, K., Gottesman, R. F., Mosley, T., Alonso, A., Coresh, J., Hill-Briggs, F., Sharrett, A. R., & Selvin, E. (2011) · Diabetologia · doi:10.1007/s00125-011-2095-7 · Cited by 77 · cited 2×
“Increased HbA1c levels have been associated with faster decline in memory and reasoning in middle-aged individuals with diabetes [12], but other cohort studies did not find such associations [35,36].”
BackgroundResultSamaras, K., Lutgers, H. L., Kochan, N. A., Crawford, J. D., Campbell, L. V., Wen, W. X., Slavin, M. J., Baune, B., Lipnicki, D. M., Brodaty, H., et al. (2014) · AGE · doi:10.1007/s11357-013-9613-0 · Cited by 75
Early Cognitive Deficits in Type 2 Diabetes: A Population-Based Study
Marseglia, A., Fratiglioni, L., Laukka, E. J., Santoni, G., Pedersen, N. L., Bäckman, L., & Xu, W. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160266 · Cited by 62 · cited 3×
“1% was added to equate the measured HbA1c values with international values [27].”
BackgroundMethodSelf-citationRelation of Dysglycemia to Structural Brain Changes in a Multiethnic Elderly Cohort
Reitz, C., Guzman, V. A., Narkhede, A., DeCarli, C. S., Brickman, A. M., & Luchsinger, J. A. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14551 · Cited by 56 · cited 3×
“In line with previous research [18,19,23], our findings further showed that neither prediabetes nor diabetes were associated with HV, a classic marker of AD-related neurodegeneration.”
BackgroundResultShort-term longitudinal trends in cognitive performance in older adults with type 2 diabetes
Fischer, A. L., de Frias, C. M., Yeung, S. E., & Dixon, R. A. (2009) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390802537636 · Cited by 55
Global brain atrophy but not hippocampal atrophy is related to type 2 diabetes
Wisse, L. E. M., de Bresser, J., Geerlings, M. I., Reijmer, Y. D., Portegies, M. L. P., Brundel, M., Kappelle, L. J., van der Graaf, Y., & Biessels, G. J. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.06.008 · Cited by 51 · cited 1×
“In line with previous research [18,19,23], our findings further showed that neither prediabetes nor diabetes were associated with HV, a classic marker of AD-related neurodegeneration.”
ResultGerritsen, L., Kalpouzos, G., Westman, E., Simmons, A., Wahlund, L.-O., Bäckman, L., Fratiglioni, L., & Wang, H.-X. (2015) · Psychological Medicine · doi:10.1017/s0033291714002293 · Cited by 51
Self-citationMarseglia, A., Dahl Aslan, A. K., Fratiglioni, L., Santoni, G., Pedersen, N. L., & Xu, W. (2018) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glx112 · Cited by 36
Self-citationShaw, M. E., Nettersheim, J., Sachdev, P. S., Anstey, K. J., & Cherbuin, N. (2017) · Brain Topography · doi:10.1007/s10548-017-0544-4 · Cited by 35 · cited 2×
“[24] reported increased cortical thickness over 12 years in nondiabetic older adults with increased blood glucose levels, although other studies found no differences in brain volumes between people with prediabetes and who are diabetes free.”
ResultLove, S., & Miners, J. S. (2017) · Clinical Science · doi:10.1042/cs20170148 · Cited by 26 · cited 1×
“In turn, dysfunction of blood-brain barrier permeability may lead to changes in the brain microvasculature and, over time, to white matter abnormalities [40,42].”
BackgroundRydwik, E., Welmer, A., Angleman, S. B., Fratiglioni, L., & Wang, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070471 · Cited by 18 · cited 1×
“Socioeconomic status (SES), derived by the longest-held occupation, was categorized into white-collar versus blue-collar workers [26].”
BackgroundSelf-citation
Cited by
Xue, M., Xu, W., Ou, Y.-N., Cao, X.-P., Tan, M.-S., Tan, L., & Yu, J.-T. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100944 · Cited by 715
Self-citationvan Sloten, T. T., Sedaghat, S., Carnethon, M. R., Launer, L. J., & Stehouwer, C. D. A. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30405-x · Cited by 702
The Impact of Disease Comorbidities in Alzheimer’s Disease
Santiago, J. A., & Potashkin, J. A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.631770 · Cited by 259
The impact of diabetes on cognitive impairment and its progression to dementia
Dove, A., Shang, Y., Xu, W., Grande, G., Laukka, E. J., Fratiglioni, L., & Marseglia, A. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12482 · Cited by 252
Self-citationPrevention of dementia in an ageing world: Evidence and biological rationale
Grande, G., Qiu, C., & Fratiglioni, L. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101045 · Cited by 229
Self-citation
Metadata
- Authors
- Marseglia, A., Fratiglioni, L., Kalpouzos, G., Wang, R., Bäckman, L., & Xu, W.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2018-08-13
- Volume
- 15
- Issue
- 1
- Pages
- 25-33
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2887398816
- Cited by
- 181
- References
- 41
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.